quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:39·17d
SECFiling
Enovis Corporation logo

SEC Form DEF 14A filed by Enovis Corporation

ENOV· Enovis Corporation
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • ENOV
    Enovis Corporation
    Health Care

Recent analyst ratings

  • Apr 17UpdateWilliam Blair-
  • Jan 6UpdateBTIG Research$41.00
  • Oct 3UpdateJMP Securities$62.00
  • Jun 13UpdateJP Morgan$53.00
  • Feb 13UpdateStephens$72.00
  • Jan 22UpdateUBS$75.00

Related

  • ANALYST7d
    William Blair resumed coverage on Enovis Corporation
  • INSIDER13d
    SEC Form 3 filed by new insider Singleton Laura Lee
  • PR14d
    Enovis to Host First Quarter 2026 Results Conference Call on May 7th
  • SEC17d
    SEC Form DEFA14A filed by Enovis Corporation
  • INSIDER21d
    SEC Form 4 filed by Ortiz Christine
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Enovis Corporation
  • INSIDER38d
    Chief Administrative Officer Engert Oliver bought $23,740 worth of shares (1,000 units at $23.74), increasing direct ownership by 2% to 48,640 units (SEC Form 4)
  • INSIDER42d
    Chief Administrative Officer Engert Oliver bought $23,930 worth of shares (1,000 units at $23.93), increasing direct ownership by 2% to 47,640 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022